Crinetics Pharmaceuticals Inc (CRNX)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Scott R. Struthers |
| Employees: | 210 |
| Web site: | crinetics.com |
|
10222 BARNES CANYON ROAD, BLDG. #2, SAN DIEGO, CA, 92121
858-450-6464
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Crinetics Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. The company is also developing CRN04777, an oral selective nonpeptide somatostatin type 5 receptor agonist, which is in phase I clinical trial for the treatment of congenital hyperinsulinism.
Please log in first to see chart